COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND

被引：0
|
作者：
Gibbons, I [1 ]
Davidson, C. [1 ]
Clark-Wright, J. [1 ]
Miller, C. [2 ]
Carroll, S. [1 ]
Costa, M. [3 ]
Bricout, H. [4 ]
Alvarez, F. P. [4 ]
机构：
[1] Sanofi Pasteur, Reading, Rdg, England
[2] Sanofi Pasteur, Church Crookham, Ham, England
[3] Syneos Hlth, London, Lon, England
[4] Sanofi Pasteur, Lyon, France
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN60
引用
收藏
页码：S554 / S554
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population
    Rumi, Filippo
    Basile, Michele
    Cicchetti, Americo
    Alvarez, Fabian P.
    Azzi, Maria Vittoria
    Muzii, Barbara
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [2] Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
    Nham, Eliel
    Seong, Hye
    Hyun, Hakjun
    Yoon, Jin Gu
    Noh, Ji Yun
    Cheong, Hee Jin
    Kim, Woo Joo
    Kim, Eugene
    Choi, Leejung
    Lee, Jung-Min
    Song, Joon Young
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [3] Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales
    Mattock, Richard
    Gibbons, Ilana
    Moss, Joe
    Mealing, Stuart
    Largeron, Nathalie
    Carroll, Stuart
    Alvarez, Fabian P.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1261 - 1271
  • [4] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    You, Joyce H. S.
    Ming, Wai-kit
    Chan, Paul K. S.
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [5] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    Joyce HS You
    Wai-kit Ming
    Paul KS Chan
    [J]. BMC Infectious Diseases, 14
  • [6] Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
    de Boer, Pieter T.
    Crepey, Pascal
    Pitman, Richard J.
    Macabeo, Berengere
    Chit, Ayman
    Postma, Maarten J.
    [J]. VALUE IN HEALTH, 2016, 19 (08) : 964 - 975
  • [7] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINE IN THE UNITED STATES
    De Boer, P. T.
    Pitman, R. J.
    Macabeo, B.
    Chit, A.
    Postma, M. J.
    Crepey, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A679 - A679
  • [8] The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
    Kohli, Michele A.
    Maschio, Michael
    Mould-Quevedo, Joaquin F.
    Drummond, Michael
    Weinstein, Milton C.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4603 - 4610
  • [9] Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China
    Jiang, Minghuan
    Li, Pengchao
    Wang, Weihua
    Zhao, Mingyue
    Atif, Naveel
    Zhu, Shan
    Fang, Yu
    [J]. VACCINE, 2020, 38 (05) : 1057 - 1064
  • [10] Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population
    Marbaix, Sophie
    Dauby, Nicolas
    Mould-Quevedo, Joaquin
    [J]. EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 608 - 619
12345